On June 24, Aimed Alliance sent a letter to the Colorado Prescription Drug Affordability Board urging it not to establish…
On June 24, Aimed Alliance sent a letter to the Colorado Prescription Drug Affordability Board urging it not to establish…
On June 15, 2026, Aimed Alliance, alongside KIF1A.ORG, sent a letter to the Massachusetts Division of Insurance and the Office…
On June 15, 2026, Aimed Alliance sent a letter to the Centers for Medicare & Medicaid Services (CMS), expressing support…
On June 16, 2026, Aimed Alliance released its latest publication, Guardrails for Care: AI and the Future of Patient Protection,…
The Food and Drug Administration’s (FDA) integration of artificial intelligence (AI) into drug development and manufacturing is expanding rapidly, but…
A recent Office of Inspector General (OIG) report investigating the impact of vertical integration in Medicare Part D highlights significant…
On May 19, Governor Spanberger vetoed H.B.483/S.B.271, which would have established a Prescription Drug Affordability Board (PDAB) in Virginia. Aimed…
On May 1, 2026, Pennsylvania filed a lawsuit against Character.ai, a generative artificial intelligence (AI) system that allow users to…
On March 23, 2026, the FTC and CVS Caremark jointly moved to withdraw from the administrative proceeding to allow the…
Aimed Alliance has released two new resources, one for consumers and one for employers, examining the growing use of alternative…